Loading...
GenSight Biologics S.A.
GSGTF•PNK
Healthcare
Biotechnology
$0.24
$0.00(0.00%)
GenSight Biologics S.A. (GSGTF) Financial Performance & Income Statement Overview
Review GenSight Biologics S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
107.18%
↑ 107.18%
Operating Income Growth
46.75%
↑ 46.75%
Net Income Growth
46.60%
↑ 46.60%
Operating Cash Flow Growth
47.54%
↑ 47.54%
Operating Margin
-1012.40%
↓ 1012.40%
Gross Margin
-34.21%
↓ 34.21%
Net Profit Margin
-1017.51%
↓ 1017.51%
ROE
77.70%
↑ 77.70%
ROIC
168.65%
↑ 168.65%
GenSight Biologics S.A. (GSGTF) Income Statement & Financial Overview
Review GenSight Biologics S.A.'s (GSGTF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $897000.00 | $1.73M | $124000.00 | $124000.00 |
| Cost of Revenue | $0.00 | $0.00 | $1.33M | $0.00 |
| Gross Profit | $897000.00 | $1.73M | -$1.20M | $124000.00 |
| Gross Profit Ratio | $1.00 | $1.00 | -$9.69 | $1.00 |
| R&D Expenses | $6.08M | $6.29M | $3.69M | $3.69M |
| SG&A Expenses | $3.23M | $2.84M | $2.74M | $2.74M |
| Operating Expenses | $9.31M | $9.13M | $6.35M | $6.35M |
| Total Costs & Expenses | $9.31M | $9.13M | $6.35M | $6.35M |
| Interest Income | $0.00 | $0.00 | $0.00 | $904500.00 |
| Interest Expense | $0.00 | $932000.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $998000.00 | $61000.00 | $548500.00 | $548500.00 |
| EBITDA | -$7.41M | -$7.34M | -$5.75M | -$5.75M |
| EBITDA Ratio | -$8.26 | -$4.25 | -$46.39 | -$46.39 |
| Operating Income | -$8.41M | -$7.40M | -$6.30M | -$6.30M |
| Operating Income Ratio | -$9.38 | -$4.28 | -$50.81 | -$50.81 |
| Other Income/Expenses (Net) | $273000.00 | $1.56M | -$828500.00 | -$829000.00 |
| Income Before Tax | -$8.14M | -$5.84M | -$7.13M | -$7.13M |
| Income Before Tax Ratio | -$9.07 | -$3.38 | -$57.50 | -$57.50 |
| Income Tax Expense | $16000.00 | $5000.00 | $1000.00 | $1000.00 |
| Net Income | -$8.15M | -$5.85M | -$7.13M | -$7.13M |
| Net Income Ratio | -$9.09 | -$3.38 | -$57.49 | -$57.49 |
| EPS | -$0.07 | -$0.07 | -$0.14 | -$0.14 |
| Diluted EPS | -$0.07 | -$0.07 | -$0.14 | -$0.14 |
| Weighted Avg Shares Outstanding | $108.85M | $82.75M | $50.56M | $50.56M |
| Weighted Avg Shares Outstanding (Diluted) | $108.85M | $82.75M | $50.56M | $50.56M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan